Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis. (Q35363970)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

0 references

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Carmela Cursaro

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Carlo Calabrese

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Antonio Craxì

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

A Gramenzi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S Fiorino

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

C Cammà

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Giunta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D Magalotti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

V Arienti

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

C Rossi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

G Di Febo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Zoli

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

G Gasbarrini

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Bernardi

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

843-848

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis C virus infection

7 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728334

Interferon treatment of cirrhotic patients with chronic hepatitis C.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728334

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728334

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728334

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728334

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728334

Prediction of variceal hemorrhage by esophageal endoscopy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728334

Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study (a report from the HCV study group of the Italian Association for the Study of the Liver).

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728334

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728334

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728334

Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatment

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728334

Prognosis of chronic hepatitis C: results of a large, prospective cohort study

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728334

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728334

Hepatitis C: somber views of natural history and optimistic views of interferon treatment?

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728334

Determinants of outcome of compensated hepatitis C virus-related cirrhosis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728334

Long-term course of interferon-treated chronic hepatitis C.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728334

Efficacy of a surveillance program for early detection of hepatocellular carcinoma

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728334

Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease

26 September 2018

1 reference

12 December 2020

Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma

1 reference

12 December 2020

Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study

1 reference

12 December 2020

Interferon and hepatocellular carcinoma

1 reference

12 December 2020

Interferon and hepatocellular carcinoma

1 reference

12 December 2020

Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP)

1 reference

12 December 2020

Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.48.6.843

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

PubMed publication ID

11358906

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11358906%20AND%20SRC:MED&resulttype=core&format=json